Cargando…
The molecular pathogenesis of multiple myeloma
Multiple Myeloma (MM) is characterized by uncontrolled proliferation and accumulation of clonal plasma cells within the bone marrow. However, the cell of origin is a B-lymphocyte acquiring aberrant genomic events in the germinal center of a lymph node as off-target events during somatichypermutation...
Autores principales: | Bolli, Niccolò, Martinelli, Giovanni, Cerchione, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772755/ https://www.ncbi.nlm.nih.gov/pubmed/33408844 http://dx.doi.org/10.4081/hr.2020.9054 |
Ejemplares similares
-
Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma
por: Cerchione, Claudio, et al.
Publicado: (2021) -
PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021) -
How I manage frontline transplant-eligible multiple myeloma in Italy
por: Montefusco, Vittorio, et al.
Publicado: (2020) -
How I manage frontline transplant-ineligible multiple myeloma
por: Derudas, Daniele, et al.
Publicado: (2020) -
The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)